Variant report
Variant | nsv457774 |
---|---|
Chromosome Location | chr2:52048275-52065967 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | 2:52043909-52049825..2:52049825-52050373 | K562 | blood: | |
2 | 2:51664217-51674289..2:52055539-52058793 | H1-hESC | embryonic stem cell: | embryo |
3 | 2:52043909-52049825..2:52049825-52050373 | K562 | blood: | |
4 | chr2:52063384..52066305-chr2:52068038..52070794,3 | K562 | blood: | |
5 | 2:51664217-51674289..2:52043909-52049825 | H1-hESC | embryonic stem cell: | embryo |
6 | chr2:52045177..52047183-chr2:52049220..52051220,2 | K562 | blood: | |
7 | chr2:52045177..52047313-chr2:52049220..52051486,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146183159 | chr2:52051852-52051853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528394358 | chr2:52051915-52051916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139050399 | chr2:52051944-52051945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540996309 | chr2:52051952-52051953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79934047 | chr2:52051989-52051990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559403463 | chr2:52052028-52052029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550329672 | chr2:52052036-52052037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568634785 | chr2:52052129-52052130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11125387 | chr2:52052145-52052146 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs373533542 | chr2:52052172-52052173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529757835 | chr2:52052202-52052203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181151030 | chr2:52052208-52052209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572792699 | chr2:52052214-52052215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533779897 | chr2:52052222-52052223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553731729 | chr2:52052224-52052225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575170226 | chr2:52052249-52052250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575564273 | chr2:52052275-52052276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371146894 | chr2:52052306-52052307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7594115 | chr2:52052339-52052340 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs563842955 | chr2:52052366-52052367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557951940 | chr2:52052391-52052392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576493941 | chr2:52052421-52052422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545588265 | chr2:52052456-52052457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78341965 | chr2:52052457-52052458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184626509 | chr2:52052458-52052459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188997227 | chr2:52052461-52052462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528521440 | chr2:52052492-52052493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546565927 | chr2:52052520-52052521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182035438 | chr2:52052543-52052544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547986084 | chr2:52052549-52052550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550366448 | chr2:52052561-52052562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572742930 | chr2:52052572-52052573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35878700 | chr2:52052600-52052601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533142533 | chr2:52052608-52052609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370610186 | chr2:52052642-52052643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146447980 | chr2:52052643-52052644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs72874614 | chr2:52052665-52052666 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs375235103 | chr2:52052670-52052671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555367453 | chr2:52052707-52052708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568790965 | chr2:52052720-52052721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561942075 | chr2:52052722-52052723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs28968777 | chr2:52052731-52052732 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs60681870 | chr2:52052745-52052746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72319270 | chr2:52052754-52052755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs398060183 | chr2:52052765-52052766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs34380984 | chr2:52052767-52052768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186417170 | chr2:52052769-52052770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546373415 | chr2:52052796-52052797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190437668 | chr2:52052802-52052803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs116183498 | chr2:52052810-52052811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52051800-52054000 | Enhancers | Hela-S3 | cervix |
2 | chr2:52052800-52053800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:52053400-52054200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr2:52053800-52054200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr2:52054200-52055000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:52054200-52068600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |